In the News

Cost Savings From GLP-1 Weight Loss Drugs Still Elusive

Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago.

In the news

About Prime Therapeutics

Prime Therapeutics logo

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn

Latest News

Login Portals
Compliance / Legal
Company
© 2025 Prime Therapeutics LLC